Bifidobacterium bifidum DS0908 and Bifidobacterium longum DS0950 Culture- Supernatants Ameliorate Obesity-Related Characteristics in Mice with High-Fat Diet- Induced Obesity
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Probiotic supplements have promising therapeutic effects on chronic diseases. In this study, we demonstrated the anti-obesity effects of two potential probiotics, Bifidobacterium bifidum DS0908 (DS0908) and Bifidobacterium longum DS0950 (DS0950). Treatment with DS0908 and DS0950 postbiotics significantly induced the expression of the brown adipocyte-specific markers UCP1, PPARγ, PGC1α, PRDM16 and beige adipocyte-specific markers CD137, FGF21, P2RX5, and COX2 in C3H10T1/2 mesenchymal stem cells (MSCs). In mice with high-fat diet (HFD)-induced obesity, both potential probiotics and postbiotics noticeably reduced body weight and epididymal fat accumulation without affecting food intake. DS0908 and DS0950 also improved insulin sensitivity and glucose use in mice with HFD-induced obesity. In addition, DS0908 and DS0950 improved the plasma lipid profile, proved by reduced triglyceride, low-density lipoprotein, and cholesterol levels. Furthermore, DS0908 and DS0950 improved mitochondrial respiratory function, confirmed by the high expression of oxidative phosphorylation proteins, during thermogenesis induction in the visceral and epididymal fat in mice with HFD-induced obesity. Notably, the physiological and metabolic changes were more significant after treatment with potential probiotic culture-supernatants than those with the bacterial pellet. Finally, gene knockdown and co-treatment with inhibitor-mediated mechanistic analyses showed that both DS0908 and DS0950 exerted anti-obesity-related effects via the PKA/p38 MAPK signaling activation in C3H10T1/2 MSCs. Our observations suggest that DS0908 and DS0950 could potentially alleviate obesity as dietary supplements.
Abstract
Probiotic supplements have promising therapeutic effects on chronic diseases. In this study, we demonstrated the anti-obesity effects of two potential probiotics, Bifidobacterium bifidum DS0908 (DS0908) and Bifidobacterium longum DS0950 (DS0950). Treatment with DS0908 and DS0950 postbiotics significantly induced the expression of the brown adipocyte-specific markers UCP1, PPARγ, PGC1α, PRDM16 and beige adipocyte-specific markers CD137, FGF21, P2RX5, and COX2 in C3H10T1/2 mesenchymal stem cells (MSCs). In mice with high-fat diet (HFD)-induced obesity, both potential probiotics and postbiotics noticeably reduced body weight and epididymal fat accumulation without affecting food intake. DS0908 and DS0950 also improved insulin sensitivity and glucose use in mice with HFD-induced obesity. In addition, DS0908 and DS0950 improved the plasma lipid profile, proved by reduced triglyceride, low-density lipoprotein, and cholesterol levels. Furthermore, DS0908 and DS0950 improved mitochondrial respiratory function, confirmed by the high expression of oxidative phosphorylation proteins, during thermogenesis induction in the visceral and epididymal fat in mice with HFD-induced obesity. Notably, the physiological and metabolic changes were more significant after treatment with potential probiotic culture-supernatants than those with the bacterial pellet. Finally, gene knockdown and co-treatment with inhibitor-mediated mechanistic analyses showed that both DS0908 and DS0950 exerted anti-obesity-related effects via the PKA/p38 MAPK signaling activation in C3H10T1/2 MSCs. Our observations suggest that DS0908 and DS0950 could potentially alleviate obesity as dietary supplements.
참고문헌 (51)
- Yoo JY, "Probiotics and prebiotics: Present status and future perspectives on metabolic disorders", Nutrients, 8, pp.173~ (2016)
- George Kerry R, "Benefaction of probiotics for human health: a review", J. Food Drug Anal, 26, pp.927~939 (2018)
- Davani-Davari D, "Prebiotics: definition, types, sources, mechanisms, and clinical applications", Foods, 8, pp.92~ (2019)
- Markowiak P, "Effects of probiotics, prebiotics, and synbiotics on human health", Nutrients, 9, pp.1021~ (2017)
- Sugahara H, "Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community", Sci. Rep, 5, pp.13548~ (2015)
- Reynés B, "Regulation of adaptive thermogenesis and browning by prebiotics and postbiotics", Front. Physiol, 9, pp.1908~ (2019)
- Rahman MS, "Bifidobacterium longum subsp. infantis YB0411 inhibits adipogenesis in 3T3-L1 pre-adipocytes and reduces high-fat-diet-induced obesity in mice", J. Agric. Food Chem, 69, pp.6032~6042 (2021)
- Hossain M, "Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508 culture-supernatant ameliorate obesity by inducing thermogenesis in obese-mice", Benef. Microbes, 11, pp.361~373 (2020)
- Hu J, "Short-chain fatty acid acetate stimulates adipogenesis and mitochondrial biogenesis via GPR43 in brown adipocytes", Endocrinology, 157, pp.1881~1894 (2016)
- Haynes VR, "A neural basis for octanoic acid regulation of energy balance", Mol. Metab, 34, pp.54~71 (2020)
- 조예진, "Obesity Regulation through Gut Microbiota Modulation and Adipose Tissue Browning", 생명과학회지, 29(8), pp.922~940 (2019), 한국생명과학회[DOI]
- Chichlowski M, "Bifidobacterium longum subspecies infantis (B. infantis) in pediatric nutrition: current state of knowledge", Nutrients, 12, pp.1581~ (2020)
- Christian M, "Elucidation of the roles of brown and brite fat genes: GPR120 is a modulator of brown adipose tissue function", Exp. Physiol, 105, pp.1201~1205 (2020)
- Cypess AM, "Brown fat as a therapy for obesity and diabetes", Curr. Opin. Endocrinol. Diabetes Obes, 17, pp.143~149 (2010)
- Zwick RK, "Anatomical, physiological, and functional diversity of adipose tissue", Cell Metab, 27, pp.68~83 (2018)
- Longo M, "Adipose tissue dysfunction as determinant of obesityassociated metabolic complications", Int. J. Mol. Sci, 20, pp.2358~ (2019)
- Ouchi N, "Adipokines in inflammation and metabolic disease", Nat. Rev. Immunol, 11, pp.85~97 (2011)
- Rosenwald M, "The origin and definition of brite versus white and classical brown adipocytes", Adipocyte, 3, pp.4~9 (2014)
- Monir Hossain, "Sinapic acid induces the expression of thermogenic signature genes and lipolysis through activation of PKA", CREB signaling in brown adipocytes, 2020, pp.53(3), 142~147[DOI]
- Loft A, "Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers", Genes Dev, 29, pp.7~22 (2015)
- Rahman MS, "Biochanin A induces a brown-fat phenotype via improvement of mitochondrial biogenesis and activation of AMPK signaling in murine C3H10T1", 2 mesenchymal stem cells, 2021, pp.35, 920~931
- Imran KM, "Cryptotanshinone promotes commitment to the brown adipocyte lineage and mitochondrial biogenesis in C3H10T1", 2 mesenchymal stem cells via AMPK and p38-MAPK signaling, 2017, pp.1862, 1110~1120
- Tzameli I, "Regulated production of a peroxisome proliferator-activated receptor-γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes", J. Biol. Chem, 279, pp.36093~36102 (2004)
- Becerril S, "Role of PRDM16 in the activation of brown fat programming. Relevance to the development of obesity", Histol. Histopathol, 28, pp.1411~1425 (2013)
- Wang W, "A PRDM16-driven metabolic signal from adipocytes regulates precursor cell fate", Cell Metab, 30, pp.174~189.e175 (2019)
- Ishibashi J, "Functions of Prdm16 in thermogenic fat cells", Temperature (Austin), 2, pp.65~72 (2015)
- Ventura-Clapier R, "Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α", Cardiovasc. Res, 79, pp.208~217 (2008)
- Cheng C-F, "PGC-1α as a pivotal factor in lipid and metabolic regulation", Int. J. Mol. Sci, 19, pp.3447~ (2018)
- Smith RAJ, "Mitochondrial pharmacology", Trends Pharmacol. Sci, 33, pp.341~352 (2012)
- Coleman OI, "Bacterial signaling at the intestinal epithelial interface in inflammation and cancer", Front. Immunol, 8, pp.1927~ (2017)
- Mishra A, "Microbial exposure during early human development primes fetal immune cells", Cell, 184, pp.3394~3409.e3320 (2021)
- Kim JS, "Lactobacillus porci sp. nov., isolated from small intestine of a swine", Int. J. Syst. Evol. Microbiol, 68, pp.3118~3124 (2018)
- Prasad J, "Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics", Int. Dairy J, 8, pp.993~1002 (1998)
- Heymsfield SB, "Mechanisms, pathophysiology, and management of obesity", New Eng. J. Med, 376, pp.254~266 (2017)
- Petrakis D, "Obesity - a risk factor for increased COVID-19prevalence, severity and lethality (Review)", Mol. Med. Rep, 22, pp.9~19 (2020)
- Vallianou N, "Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives", Curr. Obes. Rep, 9, pp.179~192 (2020)
- Rosen ED, "Transcriptional regulation of adipogenesis", Genes Dev, 14, pp.1293~1307 (2000)
- Mota de Sá P, "Transcriptional regulation of adipogenesis", Comp. Physiol, 7, pp.635~674 (2017)
- Rajesh Y, "Association of adipose tissue and adipokines with development of obesity-induced liver cancer", Int. J. Mol. Sci, 22, pp.2163~ (2021)
- Deng Y, "Adipokines as novel biomarkers and regulators of the metabolic syndrome", Ann. N Y Acad. Sci, 1212, pp.E1~E19 (2010)
- An HM, "Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats", Lipids Health Dis, 10, pp.116~ (2011)
- Arias-Mutis OJ, "Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit", PLoS One, 12, pp.e0178315~ (2017)
- Liu Y, "The ameliorative effect of Lactobacillus plantarum Y44 oral administration on inflammation and lipid metabolism in obese mice fed with a high fat diet", Food Funct, 11, pp.5024~5039 (2020)
- Soundharrajan I, "Positive metabolic effects of selected probiotic bacteria on diet-induced obesity in mice are associated with improvement of dysbiotic gut microbiota", FASEB J, 34, pp.12289~12307 (2020)
- Stine RR, "EBF2 promotes the recruitment of beige adipocytes in white adipose tissue", Mol. Metab, 5, pp.57~65 (2016)
- Lee P, "Functional thermogenic beige adipogenesis is inducible in human neck fat", Int. J. Obes, 38, pp.170~176 (2014)
- Miyamoto J, "Nutritional signaling via free fatty acid receptors", Int. J. Mol. Sci, 17, pp.450~ (2016)
- Ichimura A, "Free fatty acid receptors as therapeutic targets for the treatment of diabetes", Front. Pharmacol, 5, pp.236~ (2014)
- Wang A, "Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells", J. Nutr, 142, pp.1~6 (2011)
- Wauson EM, "G protein-coupled receptors and the regulation of autophagy", Trends Endocrinol. Metab, 25, pp.274~282 (2014)
- Barella LF, "Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes", FEBS J, 288, pp.2622~2644 (2021)